Guest Blog–Molecular Characterization Initiative (MCI) Continues to Enroll
March 6, 2023 CAC2 Community News, Guest Blogs
In March last year, the CCDI Molecular Characterization Initiative (MCI) launched. Since then, it has opened enrollment to children, adolescents, and young adults newly diagnosed with central nervous system tumors, soft tissue sarcomas, and rare tumors—with plans to expand. Results have been returned to more than 750 participants.
Data released from the initiative are searchable through the database of Genotypes and Phenotypes and Seven Bridges’ Cancer Genomics Cloud. See Where Can These Data Be Accessed? on the MCI web page for more information about access.
Enrollment continues and participation is free. Potential participants must also be receiving care from a Children’s Oncology Group–affiliated hospital.
- Blog Posts (65)
- Guest Blogs (18)
- Member Blogs (24)
- Survivorship Matters Blog (9)
- CAC2 News (20)
- Collaborative Achievements (13)
- Community News (159)
- News Digest (119)
- Research Explained (10)
- Webinars (61)
#CancelChildhoodCancer (1) Advocacy (47) Annual Summit (7) Awareness (20) AYA (2) Best Practices (12) Biorepositories (2) CAC2 News (7) CAC2 Project Incubator (1) CAC2 Projects (11) Call to Action (24) Cancer Moonshot (1) Clinical Trials (10) COG (2) Collaboration (11) Comparative Oncology (1) Data (15) Delayed Diagnosis (2) Digest (12) Drug Development (12) Drug Shortages (2) Ethics (1) Family Support (14) FDA (1) Funding Research (6) Genomics (6) Industry Perspective (5) Member Access (12) NCI (3) Nutrition (1) Patient-Reported Outcomes (1) Prevention (5) Psychosocial Support (4) Rare and Ultra Rare Cancer (1) Rare Cancers (1) Regulations (3) Research (38) Research Advocacy (1) Survivorship (26) Venture Philanthropy (3)
- CAC2 Childhood Cancer Community News Digest (March 13-19)
- CAC2 Childhood Cancer Community News Digest (March 6-12)
- Make Your Voice Heard Alliance for Childhood Cancer Action Days 2023
- CAC2 Childhood Cancer Community News Digest (February 27-March 5)
- Guest Blog–Molecular Characterization Initiative (MCI) Continues to Enroll